Gip-Based Mixed Agonists For Treatment Of Metabolic Disorders And Obesity

Patent No. EP2952202 (titled "Gip-Based Mixed Agonists For Treatment Of Metabolic Disorders And Obesity") was filed by Indiana University Research And Technology on Jun 16, 2009. The application was issued on Oct 18, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MAIWALDJul 17, 2018NEUEFEIND

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2952202

INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY
Application Number
EP15175377A
Filing Date
Jun 16, 2009
Status
Opposition Rejected
Mar 13, 2020
Publication Date
Oct 18, 2017